Pacific Biosciences Stock Forecast - Accumulation Distribution
| PACB Stock | USD 2.58 0.09 3.37% |
Pacific Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pacific Biosciences stock prices and determine the direction of Pacific Biosciences of's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pacific Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Pacific Biosciences' share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.14) | EPS Estimate Current Year (0.54) | EPS Estimate Next Year (0.51) | Wall Street Target Price 2.4167 | EPS Estimate Current Quarter (0.14) |
Using Pacific Biosciences hype-based prediction, you can estimate the value of Pacific Biosciences of from the perspective of Pacific Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pacific Biosciences using Pacific Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pacific using crowd psychology based on the activity and movement of Pacific Biosciences' stock price.
Pacific Biosciences Short Interest
A significant increase or decrease in Pacific Biosciences' short interest from the previous month could be a good indicator of investor sentiment towards Pacific. Short interest can provide insight into the potential direction of Pacific Biosciences stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.5347 | Short Percent 0.1281 | Short Ratio 5.32 | Shares Short Prior Month 34.3 M | 50 Day MA 2.0746 |
Pacific Biosciences Hype to Price Pattern
Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacific Biosciences Implied Volatility | 1.67 |
Pacific Biosciences' implied volatility exposes the market's sentiment of Pacific Biosciences of stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pacific Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pacific Biosciences stock will not fluctuate a lot when Pacific Biosciences' options are near their expiration.
Pacific Biosciences after-hype prediction price | USD 2.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Pacific Biosciences to cross-verify your projections. Prediction based on Rule 16 of the current Pacific contract
Based on the Rule 16, the options market is currently suggesting that Pacific Biosciences of will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-03-20 option contract. With Pacific Biosciences trading at USD 2.58, that is roughly USD 0.002693 . If you think that the market is fully incorporating Pacific Biosciences' daily price movement you should consider acquiring Pacific Biosciences of options at the current volatility level of 1.67%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Pacific Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Pacific Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Pacific Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Pacific Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Pacific Biosciences' open interest, investors have to compare it to Pacific Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Pacific Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Pacific. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Pacific Biosciences Additional Predictive Modules
Most predictive techniques to examine Pacific price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacific using various technical indicators. When you analyze Pacific charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 985540.0 | 424479.0 |
| Check Pacific Biosciences Volatility | Backtest Pacific Biosciences | Information Ratio |
Pacific Biosciences Trading Date Momentum
| On January 23 2026 Pacific Biosciences of was traded for 2.58 at the closing time. The top price for the day was 2.73 and the lowest listed price was 2.56 . The trading volume for the day was 6.8 M. The trading history from January 23, 2026 did not cause price change. The trading delta at closing time against the current closing price is 3.49% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Pacific Biosciences to competition |
Other Forecasting Options for Pacific Biosciences
For every potential investor in Pacific, whether a beginner or expert, Pacific Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pacific Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pacific. Basic forecasting techniques help filter out the noise by identifying Pacific Biosciences' price trends.Pacific Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pacific Biosciences stock to make a market-neutral strategy. Peer analysis of Pacific Biosciences could also be used in its relative valuation, which is a method of valuing Pacific Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pacific Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Pacific Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacific Biosciences shares will generate the highest return on investment. By undertsting and applying Pacific Biosciences stock market strength indicators, traders can identify Pacific Biosciences of entry and exit signals to maximize returns.
| Accumulation Distribution | 424479.0 | |||
| Daily Balance Of Power | (0.53) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 2.65 | |||
| Day Typical Price | 2.62 | |||
| Price Action Indicator | (0.11) | |||
| Period Momentum Indicator | (0.09) |
Pacific Biosciences Risk Indicators
The analysis of Pacific Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pacific Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pacific stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.98 | |||
| Semi Deviation | 4.53 | |||
| Standard Deviation | 6.17 | |||
| Variance | 38.1 | |||
| Downside Variance | 23.65 | |||
| Semi Variance | 20.5 | |||
| Expected Short fall | (6.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pacific Biosciences
The number of cover stories for Pacific Biosciences depends on current market conditions and Pacific Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pacific Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pacific Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pacific Biosciences Short Properties
Pacific Biosciences' future price predictability will typically decrease when Pacific Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pacific Biosciences of often depends not only on the future outlook of the potential Pacific Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pacific Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 288.4 M | |
| Cash And Short Term Investments | 389.9 M |
Check out Historical Fundamental Analysis of Pacific Biosciences to cross-verify your projections. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.06) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.